DNA damage repair inhibitors and methods for treating cancer

Details for Australian Patent Application No. 2007325900 (hide)

International Classifications

Event Publications

11 June 2009 PCT application entered the National Phase

PCT publication WO2008/066624 Priority application(s): WO2008/066624

2 July 2009 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Dana-Farber Cancer Institute; Oregon Health and Science University; DNAR, Inc., Application No. 2007325900, under INID (72) add coinventor Kennedy, Richard

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.